When Will Retatrutide Be Available FDA APPROVED Retatrutide is still in clinical trials and is not yet available for prescription. It’s currently undergoing Phase 3 trials, the last stage before potentially seeking FDA approval.
Here’s a breakdown of the expected timeline
- Phase 3 Trial Completion: Eli Lilly, the manufacturer, anticipates completing the Phase 3 trials by early 2026.
- FDA Review and Potential Approval: If the trial results are successful, Eli Lilly will submit a New Drug Application (NDA) to the FDA. The FDA review and approval process can take anywhere from a few months to over a year.
- Potential Availability: Based on this timeline, retatrutide could become available as early as late 2026 or early 2027 if the FDA approval process goes smoothly.
Important Note: Currently, the only way to access retatrutide is through participation in clinical trials. Be wary of any online sources claiming to sell retatrutide, as these are likely counterfeit products and can be dangerous.
